Programmes de vaccination : Questions médicales fréquentes
Nom anglais: Immunization Programs
Descriptor UI:D017589
Tree Number:N02.421.726.608
Questions fréquentes et termes MeSH associés
Diagnostic
2
#1
Comment évaluer l'efficacité d'un programme de vaccination ?
L'efficacité se mesure par le taux de couverture vaccinale et la réduction des cas de maladies.
VaccinationÉvaluation des programmes
#2
Quels indicateurs de santé suivent les programmes de vaccination ?
Les indicateurs incluent le taux de vaccination, l'incidence des maladies et la mortalité.
Indicateurs de santéSurveillance épidémiologique
Symptômes
2
#1
Quels symptômes peuvent indiquer une réaction vaccinale ?
Les symptômes incluent douleur au site d'injection, fièvre légère et fatigue.
Réaction au vaccinEffets indésirables
#2
Comment différencier une maladie d'une réaction au vaccin ?
Une maladie présente des symptômes plus graves et persistants, tandis qu'une réaction est généralement bénigne.
Maladies infectieusesRéactions indésirables
Prévention
2
#1
Comment les programmes de vaccination préviennent-ils les épidémies ?
Ils augmentent l'immunité collective, réduisant ainsi la transmission des maladies infectieuses.
Immunité collectivePrévention des maladies
#2
Quels vaccins sont essentiels dans les programmes de vaccination ?
Les vaccins essentiels incluent ceux contre la rougeole, la rubéole, la poliomyélite et l'hépatite B.
VaccinsMaladies infectieuses
Traitements
2
#1
Quels traitements sont recommandés pour les effets secondaires ?
Des analgésiques comme le paracétamol peuvent être utilisés pour soulager la douleur et la fièvre.
Traitement symptomatiqueEffets indésirables
#2
Que faire en cas de réaction allergique au vaccin ?
En cas de réaction allergique, il faut consulter un médecin immédiatement pour un traitement approprié.
Réaction allergiqueUrgences médicales
Complications
2
#1
Quelles sont les complications rares des vaccins ?
Les complications rares incluent des réactions allergiques sévères et des syndromes neurologiques.
Complications vaccinalesRéactions indésirables
#2
Comment gérer les complications post-vaccinales ?
Il est crucial de signaler les complications aux autorités sanitaires pour une évaluation et un suivi.
Surveillance des effets indésirablesGestion des complications
Facteurs de risque
2
#1
Quels facteurs augmentent le risque de complications vaccinales ?
Les antécédents d'allergies, les maladies immunitaires et les réactions antérieures au vaccin augmentent le risque.
Facteurs de risqueRéactions indésirables
#2
Comment les inégalités sociales affectent-elles la vaccination ?
Les inégalités sociales peuvent limiter l'accès aux vaccins et réduire la couverture vaccinale dans certaines populations.
Inégalités en santéAccès aux soins
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Programmes de vaccination : Questions médicales les plus fréquentes",
"headline": "Programmes de vaccination : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Programmes de vaccination : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-12-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Programmes de vaccination"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Services de médecine préventive",
"url": "https://questionsmedicales.fr/mesh/D011314",
"about": {
"@type": "MedicalCondition",
"name": "Services de médecine préventive",
"code": {
"@type": "MedicalCode",
"code": "D011314",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N02.421.726"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Programmes de vaccination",
"alternateName": "Immunization Programs",
"code": {
"@type": "MedicalCode",
"code": "D017589",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Valéria Conceição de Oliveira",
"url": "https://questionsmedicales.fr/author/Val%C3%A9ria%20Concei%C3%A7%C3%A3o%20de%20Oliveira",
"affiliation": {
"@type": "Organization",
"name": "Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre at the Nursing Development Research, Ribeirão Preto, SP, Brazil."
}
},
{
"@type": "Person",
"name": "Eliete Albano de Azevedo Guimarães",
"url": "https://questionsmedicales.fr/author/Eliete%20Albano%20de%20Azevedo%20Guimar%C3%A3es",
"affiliation": {
"@type": "Organization",
"name": "Universidade Federal de São João del-Rei, Campus Centro Oeste Dona Lindu, Divinópolis, MG, Brazil."
}
},
{
"@type": "Person",
"name": "Ione Carvalho Pinto",
"url": "https://questionsmedicales.fr/author/Ione%20Carvalho%20Pinto",
"affiliation": {
"@type": "Organization",
"name": "Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre at the Nursing Development Research, Ribeirão Preto, SP, Brazil."
}
},
{
"@type": "Person",
"name": "Brener Santos Silva",
"url": "https://questionsmedicales.fr/author/Brener%20Santos%20Silva",
"affiliation": {
"@type": "Organization",
"name": "PhD student in Public Health Nursing Program at the Ribeirão Preto College of Nursing at the University of São Paulo (EERP-USP), Ribeirão Preto (SP), Brazil."
}
},
{
"@type": "Person",
"name": "Alberto Camacho-Morales",
"url": "https://questionsmedicales.fr/author/Alberto%20Camacho-Morales",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Bioquímica, Facultad de Medicina, Universidad Autonoma de Nuevo León, San Nicolás de los Garza, Mexico."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cost-benefit analysis of the National Immunization Program in Spain.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39161115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/21645515.2024.2385175"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking immunization programs through the life course approach.",
"datePublished": "2024-02-29",
"url": "https://questionsmedicales.fr/article/38487192",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1355384"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Position of killed polio vaccine in the Expanded Program on Immunization].",
"datePublished": "2023-06-02",
"url": "https://questionsmedicales.fr/article/37525674",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.48327/mtsi.v3i2.2023.380"
}
},
{
"@type": "ScholarlyArticle",
"name": "Economic evaluations of immunization programs as an indispensable tool for policymakers.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/37993890",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-023-10071-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "An Introduction to the Japanese Immunization Program: Past, Present, and Future Perspectives.",
"datePublished": "2023-02-14",
"url": "https://questionsmedicales.fr/article/36795581",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/INF.0000000000003854"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Établissements, main d'oeuvre et services de soins de santé",
"item": "https://questionsmedicales.fr/mesh/D005159"
},
{
"@type": "ListItem",
"position": 3,
"name": "Services de santé",
"item": "https://questionsmedicales.fr/mesh/D006296"
},
{
"@type": "ListItem",
"position": 4,
"name": "Services de médecine préventive",
"item": "https://questionsmedicales.fr/mesh/D011314"
},
{
"@type": "ListItem",
"position": 5,
"name": "Programmes de vaccination",
"item": "https://questionsmedicales.fr/mesh/D017589"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Programmes de vaccination - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Programmes de vaccination",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Programmes de vaccination",
"description": "Comment évaluer l'efficacité d'un programme de vaccination ?\nQuels indicateurs de santé suivent les programmes de vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D017589#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Programmes de vaccination",
"description": "Quels symptômes peuvent indiquer une réaction vaccinale ?\nComment différencier une maladie d'une réaction au vaccin ?",
"url": "https://questionsmedicales.fr/mesh/D017589#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Programmes de vaccination",
"description": "Comment les programmes de vaccination préviennent-ils les épidémies ?\nQuels vaccins sont essentiels dans les programmes de vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D017589#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Programmes de vaccination",
"description": "Quels traitements sont recommandés pour les effets secondaires ?\nQue faire en cas de réaction allergique au vaccin ?",
"url": "https://questionsmedicales.fr/mesh/D017589#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Programmes de vaccination",
"description": "Quelles sont les complications rares des vaccins ?\nComment gérer les complications post-vaccinales ?",
"url": "https://questionsmedicales.fr/mesh/D017589#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Programmes de vaccination",
"description": "Quels facteurs augmentent le risque de complications vaccinales ?\nComment les inégalités sociales affectent-elles la vaccination ?",
"url": "https://questionsmedicales.fr/mesh/D017589#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un programme de vaccination ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par le taux de couverture vaccinale et la réduction des cas de maladies."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de santé suivent les programmes de vaccination ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les indicateurs incluent le taux de vaccination, l'incidence des maladies et la mortalité."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une réaction vaccinale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur au site d'injection, fièvre légère et fatigue."
}
},
{
"@type": "Question",
"name": "Comment différencier une maladie d'une réaction au vaccin ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une maladie présente des symptômes plus graves et persistants, tandis qu'une réaction est généralement bénigne."
}
},
{
"@type": "Question",
"name": "Comment les programmes de vaccination préviennent-ils les épidémies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils augmentent l'immunité collective, réduisant ainsi la transmission des maladies infectieuses."
}
},
{
"@type": "Question",
"name": "Quels vaccins sont essentiels dans les programmes de vaccination ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins essentiels incluent ceux contre la rougeole, la rubéole, la poliomyélite et l'hépatite B."
}
},
{
"@type": "Question",
"name": "Quels traitements sont recommandés pour les effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques comme le paracétamol peuvent être utilisés pour soulager la douleur et la fièvre."
}
},
{
"@type": "Question",
"name": "Que faire en cas de réaction allergique au vaccin ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de réaction allergique, il faut consulter un médecin immédiatement pour un traitement approprié."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications rares des vaccins ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications rares incluent des réactions allergiques sévères et des syndromes neurologiques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications post-vaccinales ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est crucial de signaler les complications aux autorités sanitaires pour une évaluation et un suivi."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de complications vaccinales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, les maladies immunitaires et les réactions antérieures au vaccin augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment les inégalités sociales affectent-elles la vaccination ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inégalités sociales peuvent limiter l'accès aux vaccins et réduire la couverture vaccinale dans certaines populations."
}
}
]
}
]
}
Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre at the Nursing Development Research, Ribeirão Preto, SP, Brazil.
Universidade Federal de São João del-Rei, Campus Centro Oeste Dona Lindu, Divinópolis, MG, Brazil.
Scholarship holder at the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil.
Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto, PAHO/WHO Collaborating Centre at the Nursing Development Research, Ribeirão Preto, SP, Brazil.
PhD student in Public Health Nursing Program at the Ribeirão Preto College of Nursing at the University of São Paulo (EERP-USP), Ribeirão Preto (SP), Brazil.
Departamento de Bioquímica, Facultad de Medicina, Universidad Autonoma de Nuevo León, San Nicolás de los Garza, Mexico.
Unidad de Neurometabolismo, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autonoma de Nuevo León, San Nicolás de los Garza, Mexico.
Broad benefits of vaccination programs are well acknowledged but difficult to measure, especially when considering all vaccines included in a National Immunization Program (NIP). The aim was to conduc...
The world continues to undergo a profound demographic shift toward increasing longevity -but quality of life is not improving correspondingly. At the same time, countries are taking stock of the negat...
Introducing new vaccines within national immunization programs requires careful consideration of disease- and vaccine-related issues as well as of the strength of the program and the affected health s...
In Japan, immunization is regulated by the Immunization Law, enacted shortly after World War II ended. It has been subsequently revised in response to social changes; however, after public health cond...
To analyze the reliability of records held on the National Immunization Program Information System (SI-PNI) in a subsample of children included in the national vaccination coverage survey in Brazilian...
This was a study of agreement between data recorded on vaccination cards (doses and dates) and on the SI-PNI for 4050 children with full coverage at 24 months....
Data on 3587 children were held on the SI-PNI, with losses of 11% (95%CI: 10;12). Total agreement between doses and dates in the two sources was 86% (95%CI: 86;87), however taking each dose and vaccin...
Part of the information was not recorded, but the discrepancy can be considered small. Nonetheless, underrecording of doses and children can compromise vaccination coverage estimates, altering the num...
Subsample of 4,050 children, among those completing the full schedule at 24 months studied in the national survey, 11% had not been recorded on the SI-PNI, 32% had unrecorded doses (doses or dates) an...
Recognizing the difficulties faced by the SI-PNI and the discrepancies between sources is essential for adopting initiatives to improve data quality, so as to avoid inaccurate estimates of childhood v...
This study is expected to contribute to improving the quality of records and the usability of data for monitoring vaccination coverage of the immunization program from the local to the national level....
We evaluated the public health impact and return on investment of Belgium's pediatric immunization program (PIP) from both healthcare-sector and societal perspectives....
We developed a decision analytic model for 6 vaccines routinely administered in Belgium for children aged 0-10 years: DTaP-IPV-HepB-Hib, DTaP-IPV, MMR, PCV, rotavirus, and meningococcal type C. We use...
Across all 11 pathogens, we estimated that the PIP prevented 226,000 cases of infections and 200 deaths, as well as the loss of 7,000 life-years and 8,000 quality-adjusted life-years over the lifetime...
Belgium's PIP, which previously had not been systematically assessed, provides large-scale prevention of disease-related morbidity and premature mortality, and is associated with net savings to health...
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in young children and associated with most bronchiolitis- and pneumonia-related hospitalizations. A new pre...
China's current immunization program was revised in 2007. Some common childhood vaccines such as those for influenza, pediatric pneumonia, Haemophilus influenzae, varicella, and rotavirus have not bee...
A qualitative method of in-depth interviews were conducted for this study. We interviewed 30 rural parents in a central Chinese village to investigate their awareness of non-NIP vaccines and their vac...
This study summarized the individual and social level factors influencing the non-NIP vaccination intention of rural parents. The individual level factors include four themes: perceived severity with ...
Based on these influencing factors, this study constructs a structural model for non-NIP vaccination decision-making process in rural areas of China. The results play a guiding role in directing atten...
Adherence to full vaccination is important in preventing childhood diseases. The aim of this study was to evaluate the level of compliance to full vaccination and identify the socio-cultural factors a...
The socioeconomic variables associated with each of the four binary dependent variables of whether or not a child is fully vaccinated against tetanus, BCG, measles, and pentavalent were determined usi...
While compliance to full tetanus and BCG vaccinations was > 60% at the national level, less than 50% and 10% full vaccination compliance were recorded for pentavalent and measles vaccinations, respect...
The socio-cultural factors associated with achieving full vaccination coverage in Nigeria in this study should drive the implementation of policies that will be best suited to each geopolitical zone o...